Login

PROTAC ERα Degrader-4

CAT:
804-HY-149295-02
Size:
5 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
PROTAC ERα Degrader-4 - image 1

PROTAC ERα Degrader-4

  • CAS Number: 2521299-80-7
  • UNSPSC Description: PROTAC ERα Degrader-4 is a highly potent and selectivePROTAC ERα degrader (Ki: 5.08 μM). PROTAC ERα Degrader-4 contains OBHSAs, linker and E3 ligase ligands. PROTAC ERα Degrader-4 shows excellent cell inhibitory and ERα degradation activity against Tamoxifen-sensitive and -resistant ER+ breast cancer (BC) cells and ERα-mutated BC cells. PROTAC ERα Degrader-4 can induce apoptosis and can be used for cancer research.
  • Target Antigen: Apoptosis; Estrogen Receptor/ERR; PROTACs
  • Type: Reference compound
  • Related Pathways: Apoptosis;PROTAC;Vitamin D Related/Nuclear Receptor
  • Applications: Cancer-programmed cell death
  • Field of Research: Cancer
  • Assay Protocol: https://www.medchemexpress.com/protac-erα-degrader-4.html
  • Solubility: 10 mM in DMSO
  • Smiles: CC1=C(C2=CC=C(C=C2)[C@@H](NC([C@@H]3C[C@H](CN3C([C@@H](NC(CCCCCOC4=CC=C(C=C4)N(CC(F)(F)F)S(C5C[C@@H]6C(C7=CC=C(C=C7)O)=C([C@H]5O6)C8=CC=C(C=C8)O)(=O)=O)=O)C(C)(C)C)=O)O)=O)C)SC=N1
  • Molecular Weight: 1074.23
  • References & Citations: [1]Xie B, et.al. Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo. J Med Chem. 2023 May 25;66(10):6631-6651.
  • Shipping Conditions: Blue Ice
  • Clinical Information: No Development Reported